ReviewiLIVER2023
When liver disease diagnosis encounters deep learning: Analysis, challenges, and prospects.
Review in iLIVER, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Semantic Segmentation of CT Liver Structures: A Systematic Review of Recent Trends and Bibliometric Analysis : Neural Network-based Methods for Liver Semantic Segmentation.Journal of medical systems · 2024Pooled it
- Electrocardiogram-based diagnosis of liver diseases: an externally validated and explainable machine learning approach.EClinicalMedicine · 2025Article
- Clinical and biochemical characteristics for patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome: a pilot observational study.Frontiers in neurology · 2025Article
- Machine Learning and Graph Signal Processing Applied to Healthcare: A Review.Bioengineering (Basel, Switzerland) · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The liver is the second-largest organ in the human body and is essential for digesting food and removing toxic substances. Viruses, obesity, alcohol use, and other factors can damage the liver and cause liver disease. The diagnosis of liver disease used to depend on the clinical experience of doctors, which made it subjective, difficult, and time-consuming. Deep learning has made breakthroughs in various fields; thus, there is a growing interest in using deep learning methods to solve problems in liver research to assist doctors in diagnosis and treatment. In this paper, we provide an overview of deep learning in liver research using 139 papers from the last 5 years. We also show the relationship between data modalities, liver topics, and applications in liver research using Sankey diagrams and summarize the deep learning methods used for each liver topic, in addition to the relations and trends between these methods. Finally, we discuss the challenges of and expectations for deep learning in liver research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.